tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
HALO
Halozyme
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Halozyme (HALO) Stock News & Sentiment

Compare
982 Followers
Halozyme Announces Retirement of Chief Technical Officer
Premium
Company Announcements
Halozyme Announces Retirement of Chief Technical Officer
5d ago
8K
HALO
Buy Rating for Halozyme: Potential Revenue Boost from Patent Dispute and Licensing Opportunities
Premium
Ratings
Buy Rating for Halozyme: Potential Revenue Boost from Patent Dispute and Licensing Opportunities
21d ago
HALO
Buy Rating for Halozyme: Strategic Positioning and Intellectual Property Strengths Amid Patent Dispute
Premium
Ratings
Buy Rating for Halozyme: Strategic Positioning and Intellectual Property Strengths Amid Patent Dispute
21d ago
HALO
Buy Rating for Halozyme: Potential Royalty Gains from Merck’s Keytruda and Strong Patent Position
Premium
Ratings
Buy Rating for Halozyme: Potential Royalty Gains from Merck’s Keytruda and Strong Patent Position
21d ago
HALO
Merck (MRK) Battling to Protect Key Cancer Drug as Patent Row Heats Up
Premium
Market News
Merck (MRK) Battling to Protect Key Cancer Drug as Patent Row Heats Up
22d ago
MRK
HALO
Halozyme Therapeutics: Record Earnings and Future Growth
Premium
Company Announcements
Halozyme Therapeutics: Record Earnings and Future Growth
1M ago
HALO
Buy Rating Affirmed: Halozyme’s Robust Growth and Strategic Positioning Drive Positive Outlook
Premium
Ratings
Buy Rating Affirmed: Halozyme’s Robust Growth and Strategic Positioning Drive Positive Outlook
1M ago
HALO
More HALO News >

HALO News on the Web

Myriad (MYGN) Down 17.1% Since Last Earnings Report: Can It Rebound?
Zacks
Neutral
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks
Neutral
Halozyme Announces Retirement of Chief Technical Officer
TipRanks News
Neutral
Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy?
Zacks
Neutral
Is Brookdale Senior Living (BKD) Stock Outpacing Its Medical Peers This Year?
Zacks
Neutral
HALO vs. AMGN: Which Stock Is the Better Value Option?
Yahoo Finance
Neutral
Artisan Small Cap Fund Reduced its Stake in Halozyme Therapeutics . Here’s Why
Yahoo Finance
Neutral
Should Invesco S&P MidCap 400 GARP ETF (GRPM) Be on Your Investing Radar?
Zacks
Neutral

News Score - Last 7 Days

Neutral
HALO
Sector Average
Media Buzz
This Week2 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HALO’s Media Buzz Sentiment?
Currently, no data Available
What is HALO’s weekly average amount of articles?
Currently, no data Available
What is HALO’s News Sentiment?
59% of articles about HALO were positive this week, compared to its sector average of 58%.
    Healthcare Stocks that are Trending in the News
    PLXProtalix
    DVAXDynavax
    OGNOrganon
    IMVTImmunovant
    RBOTVicarious Surgical
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing